Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Shanghai Stock Exchange 688336.SS

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Interest Coverage Ratio for the year ending December 31, 2023: 206.45

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Interest Coverage Ratio is 206.45 for the year ending December 31, 2023, a 493.87% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Interest Coverage Ratio for the year ending December 31, 2022 was 34.76, a 108.15% change year over year.
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Interest Coverage Ratio for the year ending December 31, 2021 was -426.31, a 77.68% change year over year.
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Interest Coverage Ratio for the year ending December 31, 2020 was -1,910.09, a -181.44% change year over year.
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Interest Coverage Ratio for the year ending December 31, 2019 was 2,345.47, a 813.15% change year over year.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

Shanghai Stock Exchange: 688336.SS

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

CEO	Yan Li Liu
IPO Date	July 22, 2020
Location	China
Headquarters	No. 399, Libing Road
Employees	965
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of antibody drugs in China. Its products include YISAIPU, a tumor necrosis factor inhibitor for rheumatism; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody injection; Cipterbin, an anti-HER2 monoclonal antibody. The company is also developing products for autoimmune diseases, tumors, and other diseases. The company was founded in 2002 and is based in Shanghai, China.

Key trends

Past 5 years